Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC and Conditioned Medium for Retinitis Pigmentosa
NCT05909488Phase 3Not yet recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- May 2026
- Primary completion
- Jul 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in retinitis pigmentosa (RP), sponsored by Prodia Stem Cell Indonesia. Planned start May 2026; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT05909488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909488.